Enovis Corp. (ENOV)
21.85
-0.72
(-3.19%)
USD |
NYSE |
Mar 20, 16:00
21.82
-0.02
(-0.11%)
After-Hours: 20:00
Enovis Research and Development Expense (Quarterly) : 31.36M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | 7.741M |
| Abbott Laboratories | 721.00M |
| Accuray, Inc. | 10.65M |
| Alphatec Holdings, Inc. | 22.28M |
| Plus Therapeutics, Inc. | 2.941M |